Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
60.37
+0.01 (0.02%)
Sep 1, 2026, 1:32 PM EDT - Market open
Ionis Pharmaceuticals Employees
Ionis Pharmaceuticals had 1,480 employees as of June 30, 2026. The number of employees increased by 78 or 5.56% since the number was reported on December 31, 2025.
Employees
1,480
Change
78
Growth
5.56%
Revenue / Employee
$590,603
Profits / Employee
-$381,874
Market Cap
10.03B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 1,480 | 78 | 5.56% |
| Dec 31, 2025 | 1,402 | 333 | 31.15% |
| Dec 31, 2024 | 1,069 | 142 | 15.32% |
| Dec 31, 2023 | 927 | 131 | 16.46% |
| Dec 31, 2022 | 796 | 136 | 20.61% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bio-Techne | 3,000 |
| Axsome Therapeutics | 1,346 |
| Cytokinetics | 673 |
| Crinetics Pharmaceuticals | 594 |
| Krystal Biotech | 295 |
| Kymera Therapeutics | 273 |
| Summit Therapeutics | 265 |
| Apogee Therapeutics | 261 |
IONS News
- 4 days ago - Jefferies sees neutral to negative read-through to Alnylam from AstraZeneca data - TheFly
- 12 days ago - Ionis announces new data in sHTG to be presented at ESC Congress 2026 - TheFly
- 12 days ago - Ionis to present new data strengthening leadership in the management of severe hypertriglyceridemia (sHTG) at the European Society of Cardiology Congress 2026 - Business Wire
- 13 days ago - BMO Capital starts Ionis at Market Perform pending better visibility - TheFly
- 13 days ago - Ionis Pharmaceuticals initiated with a Market Perform at BMO Capital - TheFly
- 23 days ago - IONS Investors Have Opportunity to Join Ionis Pharmaceuticals, Inc. Fraud Investigation with SBS Law - Business Wire
- 4 weeks ago - Ionis Pharmaceuticals price target raised to $76 from $72 at JPMorgan - TheFly
- 4 weeks ago - Ionis Pharmaceuticals price target raised to $93 from $90 at BofA - TheFly